NanoVibronix board reconstituted; four directors retire, five new directors elected, LTIP share pool expanded

ENvue Medical, Inc.

Christopher Fashek, Thomas Mika, Martin Goldstein, Brian Murphy retired immediately before the 2025 Annual Meeting for personal reasons; no disagreement with Company.
Stockholders elected Doron Besser, David Johnson, Zeev Rotstein, Nino Pionati, Alison Geiger Burgett as directors for one-year terms.
First Amendment to 2024 Long-Term Incentive Plan approved; shares reserved increased by 1,200,000 to 1,205,454 shares.
Share issuance proposal under Nasdaq Rule 5635(d) approved, covering convertible preferred stock and warrants from July 2025 private placement.
Kost Forer Gabbay & Kasierer (EY) ratified as independent auditor for FY 2025.

item 5.02item 5.07item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.